MATINAS BIOPHARMA HOLDINGS, INC. Net Cash Provided by (Used in) Continuing Operations
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Net Cash Provided by (Used in) Continuing Operations of -$8.25 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-31.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2015-03-31
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) continuing operations for the quarter ending 2014-12-31 was -$2.42M.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) continuing operations for the quarter ending 2014-09-30 was -$1.64M, a 113.55% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) continuing operations for the quarter ending 2014-06-30 was -$1.91M.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) continuing operations for the quarter ending 2014-03-31 was -$2.28M, a 1069.91% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) continuing operations for fiscal 2014 was -$8.25M, a 179.20% decline from fiscal 2013.
- MATINAS BIOPHARMA HOLDINGS, INC. net cash provided by (used in) continuing operations for fiscal 2013 was $10.42M.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month | Net Cash Provided by (Used in) Continuing Operations 32 month |
|---|---|---|---|---|---|
| 2014-12-31 | -$2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$4.06M derived: sum of 2 quarters · filed 2015-03-31 | -$5.97M derived: sum of 3 quarters · filed 2015-03-31 | -$8.25M 10-K · filed 2015-03-31 | |
| 2014-09-30 | -$1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$3.55M derived: sum of 2 quarters · filed 2014-11-14 | -$5.83M 10-Q · filed 2014-11-14 | -$7.57M derived: sum of 4 quarters · filed 2015-03-31 | |
| 2014-06-30 | -$1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$4.19M 10-Q · filed 2014-08-08 | -$5.93M derived: sum of 3 quarters · filed 2015-03-31 | $6.19M derived: sum of 4 quarters · filed 2015-03-31 | |
| 2014-03-31 | -$2.28M 10-Q · filed 2014-06-06 | -$4.01M derived: sum of 2 quarters · filed 2015-03-31 | $8.10M derived: sum of 3 quarters · filed 2015-03-31 | $7.90M derived: sum of 4 quarters · filed 2015-03-31 | $8.56M 10-Q · filed 2014-06-06 |
| 2013-12-31 | -$1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $10.38M derived: sum of 2 quarters · filed 2015-03-31 | $10.18M derived: sum of 3 quarters · filed 2015-03-31 | $10.42M 10-K · filed 2015-03-31 | |
| 2013-09-30 | $12.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $11.91M derived: sum of 2 quarters · filed 2014-11-14 | $12.15M 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | -$198.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $37.15K 10-Q · filed 2014-08-08 | |||
| 2013-03-31 | $235.31K 10-Q · filed 2014-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |